Messenger RNA (mRNA) vaccines became well-known during the COVID pandemic.

Following Flagship's origination of generative protein and mRNA platforms, Serif is pioneering Modified DNA medicines to program the foundational information layer of biology Serif to present data at ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

With a few chemical tweaks and some dutiful protein partners, a new biotech from Flagship Pioneering thinks it has cracked ...

Discover how specific mutations in ARS genes cause inherited peripheral neuropathies and potential avenues for targeted ...

The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger RNA to gene therapy.

Flagship Pioneering launched Serif Biomedicines to create modified DNA drugs, taking the best features of mRNA and gene ...

Nanomedicine prompts RNA to make protein-based drugs to treat diseases. Now we can fine-tune protein production by dialling ...

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), a biotechnology company focused on gene therapies for age-related ...

SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rationally designed molecular glue ...

A Honolulu research team is drawing attention far beyond the islands after reporting that an experimental mRNA therapy cut ...

We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.